Megan Vu Selected Research

AGN 211334

1/2013

Prostaglandin ethanolamides attenuate damage in a human explant colitis model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Megan Vu Research Topics

Disease

2	Colitis 01/2014 - 01/2013
1	Biliary Atresia 07/2021
1	Cholangitis 07/2021
1	Cystic Fibrosis (Mucoviscidosis) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Portal Hypertension 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Ulcerative Colitis 01/2014

Drug/Important Bio-Agent (IBA)

1	BilirubinIBA 07/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2021
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2019
1	Therapeutic UsesIBA 01/2014
1	iberogastIBA 01/2014
1	Plant Preparations (Preparation, Plant)IBA 01/2014
1	EndocannabinoidsIBA 01/2013
1	anandamide (arachidonylethanolamide)IBA 01/2013
1	AL 8810IBA 01/2013
1	AGN 211334IBA 01/2013
1	Bimatoprost (Lumigan)FDA Link 01/2013
1	ProstaglandinsIBA 01/2013
1	Prostaglandins FIBA 01/2013
1	CytokinesIBA 01/2013
1	prostaglandin F2alpha receptorIBA 01/2013

Therapy/Procedure

1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2014